The GameChanger
A new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure. 

ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.

 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2312382 

Anaphylaxis guideline: https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext 

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.

2. Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-079-H01-P
Initial release date: 03/18/2024
Expiration date: 03/18/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram